Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8558203rdf:typepubmed:Citationlld:pubmed
pubmed-article:8558203lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C0854866lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:8558203lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8558203pubmed:issue1lld:pubmed
pubmed-article:8558203pubmed:dateCreated1996-2-23lld:pubmed
pubmed-article:8558203pubmed:abstractTextCyclosporin A has been shown to reverse paclitaxel resistance in vitro by inhibiting P-gp function. Therefore, we determined whether addition of cyclosporine to paclitaxel reversed clinical paclitaxel resistance in patients with non-Hodgkin's lymphoma (NHL).lld:pubmed
pubmed-article:8558203pubmed:languageenglld:pubmed
pubmed-article:8558203pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:citationSubsetIMlld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8558203pubmed:statusMEDLINElld:pubmed
pubmed-article:8558203pubmed:monthJanlld:pubmed
pubmed-article:8558203pubmed:issn0732-183Xlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:MooreDDlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:CabanillasFFlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:SarrisA HAHlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:McLaughlinPPlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:MansfieldPPlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:RodriguezM...lld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:YounesAAlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:HagemeisterFFlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:SwanFFlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:RomagueraJJlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:NorthLLlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:CallendarDDlld:pubmed
pubmed-article:8558203pubmed:authorpubmed-author:MesinaOOlld:pubmed
pubmed-article:8558203pubmed:issnTypePrintlld:pubmed
pubmed-article:8558203pubmed:volume14lld:pubmed
pubmed-article:8558203pubmed:ownerNLMlld:pubmed
pubmed-article:8558203pubmed:authorsCompleteYlld:pubmed
pubmed-article:8558203pubmed:pagination233-9lld:pubmed
pubmed-article:8558203pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:meshHeadingpubmed-meshheading:8558203-...lld:pubmed
pubmed-article:8558203pubmed:year1996lld:pubmed
pubmed-article:8558203pubmed:articleTitleCyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.lld:pubmed
pubmed-article:8558203pubmed:affiliationDepartment of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.lld:pubmed
pubmed-article:8558203pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8558203pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8558203pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8558203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8558203lld:pubmed